Ajax-Loading

Merck & Company Inc - Interest Income

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Interest-Income" stands at 0.412 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Merck & Company Inc's third quarter result of 0.096 Billion USD for the item "Interest Income" represents an increase of 57.38 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 0.096 Billion USD for the item "Interest Income" represents a decrease of -24.41 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 0.412 Billion USD for the item "Interest Income" represents a decrease of -7.00 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.53 percent compared to the value the year prior.
The 1 year change in percent is 21.53.
The 3 year change in percent is -45.29.
The 5 year change in percent is 68.85.

The Serie's long term average value is 0.509 Billion United States Dollars. It's latest available value, on 09/30/2025, is 19.05 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2020, to it's latest available value, on 09/30/2025, is +176.51%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -62.10%.

Interest Income for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Interest Income905,699,262,464.00
LogoJohnson & Johnson - Interest Income486,508,953,600.00
LogoAbbVie Inc - Interest Income399,570,305,024.00
LogoRoche Holding AG - Interest Income317,433,206,677.55
LogoAstraZeneca PLC - Interest Income280,205,508,085.11